Impact of nicorandil in angina: Subgroup analyses

Heart

Volumn 90, Issue 12, 2004, Pages 1427-1430

  Ford, I ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; NITRATE; PLACEBO;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; THROMBOEMBOLISM; TREATMENT OUTCOME;

ANGINA PECTORIS; CONFIDENCE INTERVALS; CORONARY DISEASE; DOUBLE-BLIND METHOD; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NICORANDIL; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 10344246078     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.026310     Document Type: Article

References (21)

1. Tunstall-Pedoe H. Angina pectoris: epidemiology and risk factors. Eur Heart J 1985;6:1-5.
2. Gandhi MM. Clinical epidemiology of coronary heart disease in the UK. Br J Hosp Med 1997;58:23-7.
3. Simon S, Niamh M, Andrew W, et al. The current cost of angina pectoris to the National Health Service in the UK. Heart 2003;89:848-53.
4. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
5. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting- enzyme inhibitor, Ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53.
6. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastotin survival study (4S). Lancet 1994;344:1383-9.
7. LIPID Study Group. Prevention of cardiovascular events and death with pravastotin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57.
8. Rubins HB, Sander JR, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high density lipaprotein cholesterol. N Engl J Med 1999;341:410-8.
9. IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the impact of nicorandil in angina (IONA) randomised trial. Lancet 2002;359:1269-75.
10. Chibana T, Nagamine F, Sunagawa R, et al. Comparison of acute hemodynamic and coronary vasodilating effects between nicorandil and glyceryl trinitrate. Arzneim-Forsn/Drug Res 1991;41:6:591-4.
11. Treese N, Erbel R, Meyer J. Acute hemodynamic effects of nicorandil in coronary artery disease. J Cardiovas Pharmacol 1992;20:S3:52-6.
12. Taira N. Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: an overview. J Cardiovas Pnarmacol 1987;10:51-9.
13. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. J Cardiol 1989;63:18-24J.
14. Doring G. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stoble coronary heart disease patients. J Cardiovasc Pharm 1992;20:S74-81.
15. Di Somma S, Liguori V, Verdecchia P, et al. A double-blind comparison of nicorandil and metoprolol in patients with effort stoble angina. Cardiovasc Drugs Ther 1993;7:119-23.
16. Swan Study Group. Comparison of the antiischaemic and antianginal effect of nicorandil and amlodipine in patients with symptomatic stoble angina pectoris: the SWAN study. J Clin Basic Cardiol 1999;2:213-7.
17. Patel DJ, Purcell J, Fox KM. Cardioprotection by opening of the KATP channel in unstable angina. Eur Heart J 1999;20:51-7.
18. Tomai F, Crea F, Gaspardone A, et al. Mechanisms of cardiac pain during coronary angioplasty. J Am Coll Cardiol 1993;22:1892-6.
19. Yellon DF, Alkulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276-7.
20. Jenkins DP, Pugsley WB, Alkhulaifi AM, et al. Ischaemic preconditioning reduces tropanin T release in patients undergoing coronary bypass surgery. Heart 1997;77:314-8.
21. IONA Study Group. Impact of nicorandil in angina (IONA): design, methodology and management. Heart 2001;85:E9.